Publications by authors named "Mathieu Allez"

Claim this Profile
A
A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.
Franck Carbonnel, Nicolas Barnich, Patricia Lepage, Xavier Hébuterne, Christophe Michiels, Mathieu Allez

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease.
Hadrien Alric, Aurélien Amiot, Julien Kirchgesner, Xavier Tréton, Mathieu Allez

Inflamm Bowel Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab.
Liza Kassouri, Aurélien Amiot, Julien Kirchgesner, Xavier Tréton, Mathieu Allez

Dig Liver Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.
James O Lindsay, Mathieu Allez, Miranda Clark, Myriam Labopin, Elenor Ricart

Lancet Gastroenterol Hepatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
Franck Carbonnel, Jean Frédéric Colombel, Jérome Filippi, Konstantinos H Katsanos, Laurent Peyrin-Biroulet, Mathieu Allez

Gastroenterology· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
Odile Launay, Vered Abitbol, Anne Krivine, Lilia Ben Slama, Arnaud Bourreille, Mathieu Allez

J Crohns Colitis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
Aurelien Amiot, Vida Setakhr, Philippe Seksik, Mathieu Allez, Xavier Treton

Am J Gastroenterol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
Axel Dignass, James O Lindsay, Andreas Sturm, Alastair Windsor, Jean-Frederic Colombel, Mathieu Allez

J Crohns Colitis· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.
Laurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, Simon Campbell, Denis Franchimont, Mathieu Allez

J Crohns Colitis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
Gert Van Assche, Axel Dignass, Julian Panes, Laurent Beaugerie, John Karagiannis, Mathieu Allez

J Crohns Colitis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis